For instance, a recent study using large public datasets from The Cancer Genome Atlas and the EBRAINS brain tumor atlas, comprised primarily of tumors from white patients, showed a 16.0% performance gap in the prediction of IDH1 status in gliomas from black vs. white patients [65]. The gene discussed is IDH1; the disease is central nervous system cancer.